Larry Peiperl • UCSF Profiles

Larry Peiperl, MD

Title(s)	MD Link/Epiccare Link Access, Cio
School	Chancellor/EVC/FAS
Address	1001 Potrero Ave San Francisco CA 94110
Phone	--
vCard	Download vCard

Biography

Education and Training

University of California, San Francisco	Residency		School of Medicine
University of California, San Francisco	M.D.	1992	School of Medicine

ORNG Applications

Academic Senate

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants. Clin Vaccine Immunol. 2014 Nov; 21(11):1589-99. Frey SE, Peiperl L, McElrath MJ, Kalams S, Goepfert PA, Keefer MC, Baden LR, Lally MA, Mayer K, Blattner WA, Harro CD, Hammer SM, Gorse GJ, Hural J, Tomaras GD, Levy Y, Gilbert P, deCamp A, Russell ND, Elizaga M, Allen M, Corey L. PMID: 25253665; PMCID: PMC4248765.

View in: PubMed Mentions: 3 Fields:
All Allergy and Immunology Cli Clinical Laboratory Techniques
Translation:Humans Cells PHPublic Health CTClinical Trials
Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054). PLoS One. 2010 Oct 27; 5(10):e13579. Peiperl L, Morgan C, Moodie Z, Li H, Russell N, Graham BS, Tomaras GD, De Rosa SC, McElrath MJ, NIAID HIV Vaccine Trials Network. PMID: 21048953; PMCID: PMC2965084.

View in: PubMed Mentions: 34 Fields:
Med Medicine (General)Sci Science
Translation:Humans Cells
Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy. J Infect Dis. 2006 Sep 01; 194(5):661-5. Siddique MA, Hartman KE, Dragileva E, Dondero M, Gebretsadik T, Shintani A, Peiperl L, Valentine F, Kalams SA. PMID: 16897665.

View in: PubMed Mentions: 13 Fields:
Com Communicable Diseases
Translation:Cells